Form 4: AnaptysBio Director Hollings Renton Acquires Stock Options and Restricted Stock Units

Director Hollings Renton of AnaptysBio, Inc. was granted stock options and restricted stock units on January 7, 2025.

Summary

• Hollings Renton, a director at AnaptysBio, Inc., received stock options for 16,510 shares and 6,030 restricted stock units (RSUs) on January 7, 2025.
• The stock options have an exercise price of $14.83 per share and vest monthly starting February 7, 2025, until fully vested, contingent on continued service.
• The RSUs will vest 100% on the date of the company's 2026 annual meeting of shareholders, also contingent on continued service.
• Both the stock options and RSUs represent a right to acquire common stock of AnaptysBio.

Sentiment

Score: 7

Explanation: The document reflects a standard equity grant to a director, which is generally viewed positively as it aligns interests. There are no negative implications.

Positives

• The grant of stock options and RSUs to a director aligns their interests with those of the shareholders.
• The vesting schedule of the stock options and RSUs encourages long-term commitment from the director.

Risks

• The value of the stock options and RSUs is dependent on the future performance of AnaptysBio's stock price.
• The vesting of the options and RSUs is contingent on the director's continued service to the company.

Future Outlook

The vesting of the stock options and RSUs is contingent on the director's continued service, suggesting a long-term commitment.

Industry Context

The granting of stock options and RSUs is a common practice in the biotechnology industry to incentivize and retain key personnel.

Comparison to Industry Standards

• Stock option and RSU grants are standard practice for director compensation in publicly traded biotech companies.
• The vesting schedules are typical, with monthly vesting for options and a single vesting date for RSUs tied to a future event.
• Companies like Regeneron, Amgen, and Biogen also use similar equity-based compensation for their directors.

Stakeholder Impact

• The grant of equity to a director aligns their interests with those of shareholders.
• The vesting schedule encourages long-term commitment from the director, which can benefit the company and its stakeholders.

Key Dates

Keywords

stock options, restricted stock units, RSU, director, insider trading, equity compensation, AnaptysBio, ANAB